US2023227503A1PendingUtilityA1
Polypeptide expressed in the stratum corneum and use thereof
Est. expiryApr 27, 2030(~3.8 yrs left)· nominal 20-yr term from priority
C07K 7/08A61K 8/64A61Q 19/08A61Q 19/007C07K 7/06C07K 14/47A61K 38/00
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Polypeptides belonging to the family of late proteins of the cornified envelope (LCE), fragments of the polypeptide, isolated nucleotide sequences encoding the polypeptides, and cosmetic and/or pharmaceutical compositions containing such polypeptides are described. The polypeptides have cosmetic and/or therapeutic use to reinforce the barrier function of the epidermis, prevent and/or treat the signs of skin dryness and prevent and/or treat disorders of the barrier function or the weakening of the epidermis.
Claims
exact text as granted — not AI-modified1 . A cosmetic method for reinforcing the barrier function of the skin, comprising a step of administering to the skin of a subject who is not immunodepressed, immunodeficient, or at risk of developing an inflammatory disease, at least one analog of a fragment of at least 5 consecutive amino acids of the sequence SEQ ID No: 2 in an amount sufficient for reinforcing the barrier function of the skin by establishing covalent bonds between peptides belonging to the family of late cornified envelope proteins (LCE) and the cornified envelopes in the stratum corneum of the epidermis, under the action of endogenous transglutaminases; said analog consisting of a peptide of 5 to 15 amino acids having at least one glutamine (Gln)-lysine (Lys) domain and wherein the analog consisting of 5 to 15 amino acids as a whole has at least 80% of sequence identity with one of said fragments of the sequence SEQ ID NO:2.
Join the waitlist — get patent alerts
Track US2023227503A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.